The preventive effect of short-term administration of a herbal combination of jujube and chamomile on the symptoms of intermittent mild asthma in children under 7 years old with viral cold.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151230025772N11

Enrollment

Registered

2022-12-31

Start date

2022-12-11

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma. Other chronic obstructive pulmonary disease

Interventions

Intervention 1: Intervention group: 25 children with mild intermittent asthma will be included in the study if they meet the inclusion criteria and do not have the exclusion criteria. In addition to t

Eligibility

Sex/Gender

All

Age

No minimum to 7 Years

Inclusion criteria

Inclusion criteria: children under 7 years old Confirmation of the diagnosis of mild intermittent asthma by a pediatric immunologist based on the GINA guidelines Having an acute respiratory viral infection

Exclusion criteria

Exclusion criteria: Bacterial respiratory infection Asthma exacerbation History of allergy to herbal medicines Congenital abnormalities Any underlying disease Lack of appropriate compliance for drug treatment Failure to refer for follow-up

Design outcomes

Primary

Measure	Time frame
Cough. Timepoint: first visit , the third day, the seventh day, the fourteenth day. Method of measurement: Number of coughs per day/cough severity based on visual analog scale.;Nighttime wakeup due to coughing. Timepoint: first visit , the third day, the seventh day, the fourteenth day. Method of measurement: amount.;The amount of salbutamol usage. Timepoint: first visit , the third day, the seventh day, the fourteenth day. Method of measurement: number of puff per day.;Oral corticosteroid need. Timepoint: first visit , the third day, the seventh day, the fourteenth day. Method of measurement: has/doesn't have.;Specialist visit requierment. Timepoint: the third day, the seventh day, the fourteenth day. Method of measurement: has/doesn't have.;Need for hospital admission. Timepoint: the third day, the seventh day, the fourteenth day. Method of measurement: has/doesn't have.	—

Measure

Time frame

Cough. Timepoint: first visit , the third day, the seventh day, the fourteenth day. Method of measurement: Number of coughs per day/cough severity based on visual analog scale.;Nighttime wakeup due to coughing. Timepoint: first visit , the third day, the seventh day, the fourteenth day. Method of measurement: amount.;The amount of salbutamol usage. Timepoint: first visit , the third day, the seventh day, the fourteenth day. Method of measurement: number of puff per day.;Oral corticosteroid need. Timepoint: first visit , the third day, the seventh day, the fourteenth day. Method of measurement: has/doesn't have.;Specialist visit requierment. Timepoint: the third day, the seventh day, the fourteenth day. Method of measurement: has/doesn't have.;Need for hospital admission. Timepoint: the third day, the seventh day, the fourteenth day. Method of measurement: has/doesn't have.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Hamid Ahanchian

Islamic Azad University of medical science mashhad branch

Ahanchianh@mums.ac.ir+98 51 3225 0041

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026